About the Company
We do not have any company description for Tarsus Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second ... - Nasdaq
--Tarsus Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for ...
Tarsus Pharmaceuticals, Inc. (TARS) Q4 2023 Earnings Call Transcript
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET Company Participants Bobby Azamian - Chairman, CEO Jeff Farrow - CFO, CSO Aziz Mottiwala ...
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare ...
--Tarsus Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for ...
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call Transcript
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ETCompany ParticipantsAziz Mottiwala - Chief Commercial ...
Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 ...
News for Tarsus Pharmaceuticals Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 Trial Evaluating the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis ...
TARS Stock Quote Price and Forecast | CNN
View Tarsus Pharmaceuticals, Inc. TARS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Tarsus Pharmaceuticals Inc. Company & People | TARS | Barron's
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare ...
IRVINE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply ...
Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 ...
IRVINE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply ...
Tarsus Pharmaceuticals, Inc. Reports First Quarter 2021 Financial ...
Media Contact: SuJin Oh Shop PR (917) 841-5213 sujin@shop-pr.com Investor Contact: Patti Bank Westwicke Partners, an ICR company (415) 513-1284 IR@tarsusrx.com TARSUS PHARMACEUTICALS, INC.
Similar Companies
Loading the latest forecasts...